MedTrace Logo

Proton Radiotherapy for Recurrent Tumors

NCT01126476 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2020-04-24

No results posted yet for this study

Summary

The purpose of this study is to determine the feasibility of using proton radiotherapy for reirradiation of recurrent malignancies.

Conditions

Interventions

OTHER

Proton Radiotherapy

Sponsors & Collaborators

  • Abramson Cancer Center at Penn Medicine

    lead OTHER

Principal Investigators

  • John Plastaras, MD, PhD · Abramson Cancer Center at Penn Medicine

  • Marcio Fagundes, MD · Procure, Oklahoma City, OK

  • William F. Hartsell, MD · ProCure Proton Therapy Center, Warrenville, IL

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-02-28
Primary Completion
2017-02-28
Completion
2020-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01126476 on ClinicalTrials.gov